JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Artz, MD,MS
City of Hope Medical Center
Principal Investigator - Ankur Varma, MD,PhD
Rush University Medical Center
Principal Investigator - Arpita Gandhi, MD
Oregon Health and Science University
Principal Investigator - Bart Scott, MD
Fred Hutchinson Cancer Center
Principal Investigator - Catherine Lee, MD
Huntsman Cancer Institute/ University of Utah
Principal Investigator - Lori Muffly, MD,MS
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
Recruiting - Stanford University
Stanford, California, United States
Recruiting - Rush University Medical Center
Chicago, Illinois, United States
Recruiting - Oregon Health & Science University
Portland, Oregon, United States
Recruiting - Huntsman Cancer Institute - University of Utah
Salt Lake City, Utah, United States
Recruiting - Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Jul 2020
- Primary completion
- 15 Oct 2023
- Completion
- 8 Dec 2023
- Last update posted
- 11 Jun 2021
- Registered enrollment
- 40
- Registry id
- NCT04429191
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.